Business ❯Pharmaceutical Industry ❯Drug Market ❯Central Nervous System Treatments

Market Growth

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal

Karuna's Antipsychotic Drug KarXT Under FDA Review, Decision Expected by September 2024